Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eliot L Friedman Md"'
Autor:
Joseph Lipscomb, Eliot L Friedman Md, Alyssa N. Troeschel, Tenbroeck Smith, Kathleen Castro, Patricia D. Hegedus, Steven B. Clauser, Kenneth M. Portier, Ryan McCabe, Katherine Treiman
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 25(11)
Patient experiences with symptom care need to be assessed and documented to ensure successful management of cancer-related symptoms. This paper details one method for creating symptom management quality improvement (SMQI) reports, including case-mix
Publikováno v:
Journal of Clinical Oncology. 35:168-168
168 Background: The retrospective study aimed to evaluate carboplatin / paclitaxel (CP) versus FOLFOX in the neoadjuvant combined modality setting for newly diagnosed esophageal or junctional cancers. Methods: Patients with esophageal or junctional c
Autor:
Michael J Weiss, Robert Kruklitis Md, Brian J. Patson Md, Eliot L Friedman Md, Dennis M Sopka
Publikováno v:
Journal of Multidisciplinary Healthcare
Introduction The Institute of Medicine, the American Society of Clinical Oncology, and the European Society of Medical Oncology promote a multidisciplinary approach for the treatment of cancer. Stage III non-small-cell lung cancer (NSCLC) represents
Autor:
Robert J. Behrens, Mark D. Sborov, Heidi Mc Kean, Eliot L Friedman Md, Shauna L. Hillman, Kendrith M. Rowland, Gerald G. Gross, Michael W. Cannon, Philip J. Stella, Aminah Jatoi
How do oncologists choose therapy for the elderly? Oncologists assigned patients aged 65 years or older with incurable non-small cell lung cancer to: (a) carboplatin (AUC = 2) + paclitaxel 50 mg/m(2) days 1, 8, 15 (28-day cycle × 4) followed by gefi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cdfa186875999da6730e4d7e9de471
https://europepmc.org/articles/PMC5585010/
https://europepmc.org/articles/PMC5585010/
Autor:
Diana Tamondong-Lachica, Karen K. Fields, Hatem Soliman, Eliot L Friedman Md, Maria Czarina Acelajado, John W. Peabody, Rachel V. Lee
Publikováno v:
Journal of Clinical Oncology. 31:96-96
96 Background: Although clinical pathways have the promise to improve the quality of care, they have had limited success changing practice or standardizing care. Moffitt Cancer Center (MCC) has > 40 pathways incorporating interdisciplinary care strat
Autor:
Eliot L Friedman Md, Jana Eisenstein, Robert D. Siegel, Irene Prabhu Das, Kathleen Castro, Steven B. Clauser, Nadesa Mack
Publikováno v:
Journal of Clinical Oncology. 31:178-178
178 Background: The National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) was initiated to expand cancer research and deliver quality cancer care in communities. A program goal was support of quality care initiatives. Twenty-one co
Publikováno v:
Journal of Clinical Oncology. 31:82-82
82 Background: Treatment of stage III NSCLC involves surgery, radiation therapy and chemotherapy. Treatment depends on the size and location of the primary tumor and lymph nodes as well as clinical status of the patient. Evaluation of these patients
Autor:
Margaret Currens, Kathleen Castro, Irene Prabhu Das, Paul Morris, Silvana Rivero, Steven B. Clauser, Angela Carrigan, Eliot L Friedman Md
Publikováno v:
Journal of Clinical Oncology. 30:67-67
67 Background: A key aim of the NCCCP is to develop and improve the quality of multidisciplinary care (MDC). An assessment tool with nine key elements relevant to MDC structure and operations was developed to assess MDC maturity and set goals for con
Autor:
Eliot L Friedman Md, Basil Ahmed, Dana Wentzel, Sherrine Eid, Brian Zimmer, Nelson Kopyt, James F. Reed
Publikováno v:
Blood. 108:5521-5521
NHANES survey estimates the prevalence of CKD to be approximately 11% in the general population and 25% in the population over 65 years of age, and the prevalence of Chronic Kidney Disease (CKD) associated anemia approaches 75% in Stage 5 CKD. Despit
Publikováno v:
Journal of Thoracic Oncology. (7):1116-1117